Thrombotic complications associated with novel coronavirus infection COVID – 19

A clinical case of a fatal thrombotic complication in a patient with a new coronavirus infection (NCVI) COVID-19 in the convalescent period is presented. A retrospective analysis of the patient's medical record with the chronology of laboratory and instrumental studies, the clinical course and the applied methods of intensive care was carried out. The algorithm of pulmonary embolism (PE) diagnosis, validity and decision-making concerning thrombolytic therapy and extracorporeal membrane oxygenation are shown. The results of autopsy are  presented as well , confirming the diagnosis of PE and the appropriateness of medical interventions

1. Vremennye metodicheskie rekomendacii. «Profilaktika, diagnostika i lechenie novoj koronavirusnoj infekcii COVID-19» [Temporary guidelines. Prevention, diagnosis and treatment of the COVID-19. Version 14. М. 2021 (In Russ.).]

2. Galstyan G.M. Koagulopatiya pri COVID-19 [Coagulopathy in COVID-19]. Pul'monologiya [Pulmonology. 2020; 30 (5): 645 – 657 (In Russ.).]

3. Zagidullin N.SH., Gareeva D.F., Ishmetov V.S. [et al.] Renin-angiotenzinovaya sistema pri novoj koronavirusnoj infekcii COVID 2019 [Renin-angiotensin-aldosterone system in new coronavirus infection 2019]. Arterial'naya gipertenziya [Arterial Hypertension. 2020; 26(3): 240-247 (In Russ.).]

4. Yavelov I.S., Drapkina O.M. COVID-19: state of hemostasis system and features of antithrombotic therapy. Cardiovascular therapy and prevention. 2020; 19 (3): 310 – 318 (In Russ.).]

5. Aimes R.T., Zijlstra A., Hooper J.D. Endothelial cell serine proteases expressed during vascular morphogenesis and angiogenesis. Thromb. Haemost. 2003; 89 (3): 561-572.

6. Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). European Heart Journal. 2020; 41: 543-603.

7. Guo T, Fan Y, Chen M, Wu X, Zhang L, and He T. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020; 5: 811-818. http://dx.doi.org/10.1001/jamacardio.2020.1017.

8. Hamming I, Timens W, Bulthuis M.L. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol. 2004; 203 (2): 631-637. doi:10.1002/path.1570.

9. Lu R, Zhao X, Li J. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395: 565-574. doi:10.1016/S01406736(20)30251-8.

10. Varga Z, Flammer A.J., Steiger P. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395:1417-1418. doi:10.1016/S0140-6736(20)30937-5.